This is a joint event between the ABPI and the BIA which will focus on the adaptive licensing approach to the authorisation of medicines and how medicine developers across the life science sector can engage.
The timely meeting will explain the practicalities of how to participate in the EMA adaptive licensing pilot, coming just weeks after the pilot has been launched by the EMA and will discuss how the UK life science eco-system will capitalise on this opportunity.
Why you should attend This event will provide details of the adaptive licensing approach, as well as explain how companies with candidate products can come forward and participate in this exciting opportunity.
Who should attend This event will be of interest to those involved in research and development of new medicines, regulatory strategy, and those in a commercial role responsible for the introduction of new medicines in the UK and Europe.
How to register Please click here to register. Places on this workshop are limited and will be offered on a first come, first served basis. A fee of £50 + VAT will be charged to cover administrative costs. Book early to guarantee your place.
Date and time Monday 2 June 2014, 9.30am to 1.00pm
Taylor Wessing 5 New Street Square London EC4A 3TW
If you have any further queries please contact Ivan Dennie, ABPI Events Manager firstname.lastname@example.org.